"GOLD or lower limit of normal definition? a comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study"

BackgroundThe Global initiative for chronic Obstructive Lung Disease (GOLD) defines COPD as a fixed post-bronchodilator ratio of forced expiratory volume in 1 second and forced vital capacity (FEV1/FVC) below 0.7. Age-dependent cut-off values below the lower fifth percentile (LLN) of this ratio derived from the general population have been proposed as an alternative. We wanted to assess the diagnostic accuracy and prognostic capability of the GOLD and LLN definition when compared to an expert-based diagnosis.MethodsIn a prospective cohort study, 405 patients aged ≥ 65 years with a general practitioner's diagnosis of COPD were recruited and followed up for 4.5 (median; quartiles 3.9; 5.1) years. Prevalence rates of COPD according to GOLD and three LLN definitions and diagnostic performance measurements were calculated. The reference standard was the diagnosis of COPD of an expert panel that used all available diagnostic information, including spirometry and bodyplethysmography.ResultsCompared to the expert panel diagnosis, 'GOLD-COPD' misclassified 69 (28%) patients, and the three LLNs misclassified 114 (46%), 96 (39%), and 98 (40%) patients, respectively. The GOLD classification led to more false positives, the LLNs to more false negative diagnoses. The main predictors beyond the FEV1/FVC ratio for an expert diagnosis of COPD were the FEV1 % predicted, and the residual volume/total lung capacity ratio (RV/TLC). Adding FEV1 and RV/TLC to GOLD or LLN improved the diagnostic accuracy, resulting in a significant reduction of up to 50% of the number of misdiagnoses. The expert diagnosis of COPD better predicts exacerbations, hospitalizations and mortality than GOLD or LLN.ConclusionsGOLD criteria over-diagnose COPD, while LLN definitions under-diagnose COPD in elderly patients as compared to an expert panel diagnosis. Incorporating FEV1 and RV/TLC into the GOLD-COPD or LLN-based definition brings both definitions closer to expert panel diagnosis of COPD, and to daily clinical practice.

[1]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[2]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[3]  A. Worster,et al.  Incorporation bias in studies of diagnostic tests: how to avoid being biased about bias. , 2008, CJEM.

[4]  A. Buist,et al.  Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.

[5]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[6]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[7]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[8]  J Carpenter,et al.  Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. , 2000, Statistics in medicine.

[9]  C. van Weel,et al.  Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care , 2008, European Respiratory Journal.

[10]  C. Furberg,et al.  Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2008, JAMA.

[11]  J. E. Hansen,et al.  Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. , 2007, Chest.

[12]  K. Wood,et al.  FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. , 2006, Chest.

[13]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[14]  C. Blanchette,et al.  Economic Burden in Direct Costs of Concomitant Chronic Obstructive Pulmonary Disease and Asthma in a Medicare Advantage Population , 2008, Journal of managed care pharmacy : JMCP.

[15]  P. Nieminen,et al.  Early detection of COPD combined with individualized counselling for smoking cessation: A two-year prospective study , 2010, Scandinavian journal of primary health care.

[16]  David J Murphy,et al.  Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2008, JAMA.

[17]  S Greenland,et al.  A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.

[18]  P. Enright,et al.  Spirometry and maximal respiratory pressure references from healthy Minnesota 65- to 85-year-old women and men. , 1995, Chest.

[19]  F. Rutten,et al.  The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease , 2009, European journal of heart failure.

[20]  F. Rutten,et al.  Heart failure and chronic obstructive pulmonary disease: An ignored combination? , 2006, European journal of heart failure.

[21]  D. Dusser,et al.  The effect of tiotropium on exacerbations and airflow in patients with COPD. , 2006, The European respiratory journal.

[22]  P. Primatesta,et al.  Prediction equations for normal and low lung function from the Health Survey for England , 2004, European Respiratory Journal.

[23]  R. Pistelli,et al.  Validation of FEV6 in the elderly: correlates of performance and repeatability , 2007, Thorax.

[24]  P. Calverley.  The GOLD classification has advanced understanding of COPD. , 2004, American journal of respiratory and critical care medicine.

[25]  A. Albert,et al.  A bootstrap method for comparing correlated kappa coefficients , 2008 .

[26]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[27]  Diederick E Grobbee,et al.  When should we remain blind and when should our eyes remain open in diagnostic studies? , 2002, Journal of clinical epidemiology.

[28]  E. Salpeter,et al.  Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. , 2004, Chest.

[29]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[30]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[31]  F. Rutten,et al.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. , 2005, European heart journal.

[32]  H. Kerstjens.  The GOLD classification has not advanced understanding of COPD. , 2004, American journal of respiratory and critical care medicine.

[33]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[34]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[35]  P. Enright,et al.  Lung volumes in 4,774 patients with obstructive lung disease. , 1999, Chest.